Drug: LAMIVUDINE. Injury: Foetal exposure during pregnancy Quarter: 2016Q3
Total Records: 70 Number of Pages: 4
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 125231121 | LAMIVUDINE. | Foetal exposure during pregnancy | BRISTOL MYERS SQUIBB | 0.00 DY | M | 2 KG | 20160701 | PR |
| 125272611 | LAMIVUDINE. | Foetal exposure during pregnancy | VIIV | 0.00 | M | 3 KG | 20160705 | COUNTRY NOT SPECIFIED |
| 126282221 | LAMIVUDINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160808 | IT | |
| 126282491 | LAMIVUDINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160808 | IT | |
| 126282571 | LAMIVUDINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160808 | IT | |
| 126282591 | LAMIVUDINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160808 | IT | |
| 126282621 | LAMIVUDINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160808 | IT | |
| 126282771 | LAMIVUDINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160808 | IT | |
| 126283311 | LAMIVUDINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160808 | IT | |
| 126283671 | LAMIVUDINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160808 | IT | |
| 126874891 | LAMIVUDINE. | Foetal exposure during pregnancy | RANBAXY | 0.00 | 0 | 20160826 | CH | |
| 126894951 | LAMIVUDINE. | Foetal exposure during pregnancy | ROCHE | 0.00 | 0 | 20160826 | US | |
| 127028581 | LAMIVUDINE. | Foetal exposure during pregnancy | VIIV | 0.00 | F | 0 | 20160831 | MZ |
| 127029621 | LAMIVUDINE. | Foetal exposure during pregnancy | GLAXOSMITHKLINE | 0.00 | F | 0 | 20160831 | MZ |
| 127044881 | LAMIVUDINE. | Foetal exposure during pregnancy | MERCK | 1.00 DY | M | 0 | 20160831 | US |
| 127304261 | LAMIVUDINE. | Foetal exposure during pregnancy | ABBVIE | 0.00 | 0 | 20160909 | COUNTRY NOT SPECIFIED | |
| 127304281 | LAMIVUDINE. | Foetal exposure during pregnancy | ABBVIE | 0.00 | 0 | 20160909 | COUNTRY NOT SPECIFIED | |
| 127304291 | LAMIVUDINE. | Foetal exposure during pregnancy | ABBVIE | 0.00 | 0 | 20160909 | COUNTRY NOT SPECIFIED | |
| 127428941 | LAMIVUDINE. | Foetal exposure during pregnancy | MYLAN | 0.00 | 0 | 20160914 | MZ | |
| 127460501 | LAMIVUDINE. | Foetal exposure during pregnancy | CIPLA | 0.00 | 0 | 20160915 | US |
Total Records: 70 Number of Pages: 4